On January 29, 2026, PatientRightsAdvocate.org (PRA) issued a statement praising the Department of Labor (DOL) under the Trump Administration for implementing a rule requiring insurance carriers to disclose true prices and intermediary fees related to their pharmacy benefit manager subsidiaries. This move aims to increase transparency and combat profiteering within the industry.